bf/NASDAQ:LEGN_icon.jpeg

NASDAQ:LEGN

Legend Biotech

  • Stock

33.96

−2.83%

−3.54

USD last updated 16/08 01:55:59

Last Close

37.50

15/08 20:06

Market Cap

8.63B

Beta: −0.08

Volume Today

521.83K

Avg: 810.09K

PE Ratio

−39.80

PFCF: −29.36

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comp...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1-0.50.52019-06-302020-11-162022-06-012023-11-202024-09-20

    Revenue (Estimate*)

    50M100M150M2019-06-302020-11-162022-06-012023-11-202024-09-20

    *Estimate based on analyst consensus